IDEAS home Printed from
   My bibliography  Save this article

Cost containment and health care reform: a study of the European Union


  • Abel-Smith, Brian
  • Mossialos, Elias


No abstract is available for this item.

Suggested Citation

  • Abel-Smith, Brian & Mossialos, Elias, 1994. "Cost containment and health care reform: a study of the European Union," Health Policy, Elsevier, vol. 28(2), pages 89-132, May.
  • Handle: RePEc:eee:hepoli:v:28:y:1994:i:2:p:89-132

    Download full text from publisher

    File URL:
    Download Restriction: Full text for ScienceDirect subscribers only

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    1. Huttin, Christine, 1994. "The use of prescription charges," Health Policy, Elsevier, vol. 27(1), pages 53-73, January.
    2. Manning, Willard G, et al, 1987. "Health Insurance and the Demand for Medical Care: Evidence from a Randomized Experiment," American Economic Review, American Economic Association, vol. 77(3), pages 251-277, June.
    3. Keeler, Emmett B. & Relles, Daniel A. & Rolph, John E., 1977. "The choice between family and individual deductibles in health insurance policies," Journal of Economic Theory, Elsevier, vol. 16(2), pages 220-227, December.
    4. Feldman, Roger & Dowd, Bryan, 1991. "Must adverse selection cause premium spirals?," Journal of Health Economics, Elsevier, vol. 10(3), pages 349-357, October.
    5. Pauly, Mark V, 1986. "Taxation, Health Insurance, and Market Failure in the Medical Economy," Journal of Economic Literature, American Economic Association, vol. 24(2), pages 629-675, June.
    6. Marquis, M. Susan, 1992. "Adverse selection with a multiple choice among health insurance plans: A simulation analysis," Journal of Health Economics, Elsevier, vol. 11(2), pages 129-151, August.
    7. Wolfe, John R. & Goddeeris, John H., 1991. "Adverse selection, moral hazard, and wealth effects in the medigap insurance market," Journal of Health Economics, Elsevier, vol. 10(4), pages 433-459.
    8. Marquis, M Susan & Phelps, Charles E, 1987. "Price Elasticity and Adverse Selection in the Demand for Supplementary Health Insurance," Economic Inquiry, Western Economic Association International, vol. 25(2), pages 299-313, April.
    9. Leibowitz, Arleen & Manning, Willard G. & Newhouse, Joseph P., 1985. "The demand for prescription drugs as a function of cost-sharing," Social Science & Medicine, Elsevier, vol. 21(10), pages 1063-1069, January.
    10. O'Brien, Bernie, 1989. "The effect of patient charges on the utilisation of prescription medicines," Journal of Health Economics, Elsevier, vol. 8(1), pages 109-132, March.
    Full references (including those not matched with items on IDEAS)


    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.

    Cited by:

    1. Borras, Josep M. & Granados, Alicia & Escarrabill, Joan & de Lissovoy, Gregory, 1996. "Complex decisions about an uncomplicated therapy: reimbursement for long-term oxygen therapy in Catalonia (Spain)," Health Policy, Elsevier, vol. 35(1), pages 53-59, January.
    2. Lopez-Casasnovas, Guillem & Puig-Junoy, Jaume, 2000. "Review of the literature on reference pricing," Health Policy, Elsevier, vol. 54(2), pages 87-123, November.
    3. Eulàlia Dalmau & Jaume Puig, 1997. "Market structure and hospital efficiency: Evaluating potential effects of deregulation in a national health service," Working Papers, Research Center on Health and Economics 214, Department of Economics and Business, Universitat Pompeu Fabra.
    4. Liaropoulos, Lycurgus & Tragakes, Ellie, 1998. "Public/private financing in the Greek health care system: implications for equity," Health Policy, Elsevier, vol. 43(2), pages 153-169, February.
    5. Blazej Lyszczarz, 2016. "The effect of health care model on health systems' responses to economic crises," Ekonomia i Prawo, Uniwersytet Mikolaja Kopernika, vol. 15(4), pages 493-501, December.
    6. Prosser, Helen & Walley, Tom, 2005. "A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing," Social Science & Medicine, Elsevier, vol. 60(6), pages 1335-1346, March.
    7. Eulália Dalmau-Atarrodona & Jaume Puig-Junoy, 1998. "Market Structure and Hospital Efficiency: Evaluating Potential Effects of Deregulation in a National Health Service," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 13(4), pages 447-466, August.
    8. Liaropoulos, Lycurgus L., 1995. "Health services financing in Greece: a role for private health insurance," Health Policy, Elsevier, vol. 34(1), pages 53-62, October.
    9. Eulàlia Dalmau & Jaume Puig, 1997. "Market structure and hospital efficiency: Evaluating potential effects of deregulation in a national health service," Economics Working Papers 214, Department of Economics and Business, Universitat Pompeu Fabra.
    10. Aletras, Vassilios & Kontodimopoulos, Nick & Zagouldoudis, Athanasios & Niakas, Dimitris, 2007. "The short-term effect on technical and scale efficiency of establishing regional health systems and general management in Greek NHS hospitals," Health Policy, Elsevier, vol. 83(2-3), pages 236-245, October.
    11. Gevers, J.M.P. & Gelissen, J.P.T.M. & Arts, W.A. & Muffels, R.J.A., 1999. "Public health care in balance : Exploring popular support for health care systems in the European Union," WORC Paper 99.12.04, Tilburg University, Work and Organization Research Centre.
    12. repec:eee:hepoli:v:121:y:2017:i:9:p:947-954 is not listed on IDEAS
    13. Schneeweiss, Sebastian & Schoffski, Oliver & Selke, Gisbert W, 1998. "What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?," Health Policy, Elsevier, vol. 44(3), pages 253-260, June.
    14. Schmid, Achim & Siemsen, Pascal & Götze, Ralf, 2015. "Keeping an eye on IRIS: Risk and income solidarity in OECD healthcare systems," TranState Working Papers 191, University of Bremen, Collaborative Research Center 597: Transformations of the State.
    15. Monrad Aas, I. H., 1995. "Incentives and financing methods," Health Policy, Elsevier, vol. 34(3), pages 205-220, December.

    More about this item


    Access and download statistics


    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:28:y:1994:i:2:p:89-132. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Dana Niculescu) or (). General contact details of provider: .

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.